Global Wound Care Biologics Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2023 –2029 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
|
 TCAC |
% |
| Principaux acteurs du marché |
|
>Marché mondial des produits biologiques pour le traitement des plaies, par produit (substituts cutanés biologiques, agents topiques), type de plaie (ulcères, plaies chirurgicales et traumatiques, brûlures), utilisateur final (hôpitaux, centres de soins intensifs, centres de traitement des brûlures et cliniques de traitement des plaies) – Tendances et prévisions de l’industrie jusqu’en 2029
Analyse et taille du marché
Le diabète est devenu une maladie courante dans tous les pays développés et agricoles. Le diabète devient de plus en plus courant d'année en année, ouvrant la voie à des acteurs majeurs sur le marché du traitement. Le marché des produits biologiques pour le traitement des plaies est l'un des gagnants. La population diabétique croissante est considérée comme un facteur majeur de la croissance du marché mondial des produits biologiques pour le traitement des plaies. De nombreux patients diabétiques souffrent d'ulcères diabétiques, qui nécessitent des interventions chirurgicales mineures et des soins. Après une intervention médicale, la plaie du patient est généralement recouverte d'un pansement contenant des médicaments pour la cicatrisation. Les produits biologiques pour le traitement des plaies fournissent de tels éléments, qui contribuent à améliorer la productivité du traitement.
Selon les analyses de Data Bridge Market Research, le marché des produits biologiques pour le traitement des plaies devrait atteindre la valeur de 3,11 milliards USD d'ici 2029, à un TCAC de 3,80 % au cours de la période de prévision. L'augmentation du nombre de brûlures alimente la croissance du marché des produits biologiques pour le traitement des plaies.
Définition du marché
La cicatrisation des plaies est un processus complexe qui implique la synchronisation et l'activation de nombreux éléments intracellulaires, extracellulaires et intercellulaires, tels que la coagulation et le dépôt de collagène, l'épithélialisation, l'accrétion de tissu fibreux, la contraction de la plaie, les événements inflammatoires, la granulation et le remodelage des tissus. Les produits biologiques de soin des plaies sont des produits issus de l'ingénierie biologique utilisés pour traiter les plaies des membres inférieurs qui ne cicatrisent pas.
Portée du rapport et segmentation du marché
|
Rapport métrique |
Détails |
|
Période de prévision |
2022 à 2029 |
|
Année de base |
2021 |
|
Années historiques |
2020 (personnalisable de 2019 à 2014) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD, volumes en unités, prix en USD |
|
Segments couverts |
Par produit (substituts cutanés biologiques, agents topiques), type de plaie (ulcères, plaies chirurgicales et traumatiques, brûlures), utilisateur final (hôpitaux, centres de soins intensifs, centres de traitement des brûlures et cliniques de traitement des plaies) |
|
Pays couverts |
États-Unis, Canada et Mexique en Amérique du Nord, Allemagne, France, Royaume-Uni, Pays-Bas, Suisse, Belgique, Russie, Italie, Espagne, Turquie, Reste de l'Europe en Europe, Chine, Japon, Inde, Corée du Sud, Singapour, Malaisie, Australie, Thaïlande, Indonésie, Philippines, Reste de l'Asie-Pacifique (APAC) en Asie-Pacifique (APAC), Arabie saoudite, Émirats arabes unis, Afrique du Sud, Égypte, Israël, Reste du Moyen-Orient et de l'Afrique (MEA) en tant que partie du Moyen-Orient et de l'Afrique (MEA), Brésil, Argentine et Reste de l'Amérique du Sud en tant que partie de l'Amérique du Sud. |
|
Acteurs du marché couverts |
Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (US), Wright Medical (US), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Organogenesis (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), Lavior Inc. (US). Marine Polymer Technologies, Inc. (US), Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden) |
|
Opportunities |
|
|
|
Wound care biologics Market Dynamics
Drivers
- The increased diabetes incidence
One of the major factors driving the growth of the wound care biologics market is the increase in wound care treatment and management programmes. The rise in diabetes incidences due to obesity, poor diet, and physical inactivity, as well as the rise in chronic wounds, particularly foot ulcers, among the diabetic population, are driving market growth..
Development of better treatment options
The market is also influenced by the emphasis on the development of better treatment options, as well as the huge burden of diseases and the use of technology to deal with inflammation, tissue accumulation, collagen deposition, and the formation of epithelial cell layers
- Government investments for healthcare interoperability
The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the wound care biologics market.
Opportunities
Improvements in healthcare infrastructure, increased investment in the biotechnology sector, and an increase in healthcare expenditure all have a positive impact on profitable opportunities.
Restraints/Challenges
The high cost of wound treatment and wound care biologics is a factor that is expected to stymie market growth. During the forecast period, the risk of skin substitute failure is expected to pose a challenge to the wound care biologics market.
This wound care biologics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the wound care biologics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Wound Care Biologics Market
Les sociétés pharmaceutiques et biotechnologiques, en collaboration avec les gouvernements du monde entier, s’efforcent de faire face à l’épidémie de COVID-19, du développement de vaccins à la planification des défis de la chaîne d’approvisionnement en médicaments. Environ 115 candidats vaccins et 155 molécules sont actuellement en cours de R&D. En outre, les médicaments couramment utilisés tels que l’hydroxychloroquine ont connu une augmentation spectaculaire de la demande pour la gestion du COVID-19. Comme de nombreux pays développés manquent de ces médicaments, la forte demande a créé d’énormes opportunités pour les fabricants de médicaments de gestion du COVID-19. Les industries pharmaceutiques et biotechnologiques devraient connaître une croissance significative à l’avenir en raison de la demande de vaccins et de médicaments de traitement contre le COVID-19.
Portée du marché mondial des produits biologiques pour le traitement des plaies
Le marché des produits biologiques pour le traitement des plaies est segmenté en fonction du produit, du type de plaie et de l'utilisateur final. La croissance parmi ces segments vous aidera à analyser les segments de croissance faibles dans les industries et fournira aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.
Produit
- Substituts cutanés biologiques
- Agents topiques
Sur la base du produit, le marché des produits biologiques pour le traitement des plaies est segmenté en substituts cutanés biologiques et agents topiques. Les substituts cutanés biologiques sont eux-mêmes segmentés en produits dérivés de tissus de donneurs humains, produits dérivés d'animaux acellulaires et produits biosynthétiques.
Type de plaie
- Ulcères
- Plaies chirurgicales et traumatiques
- Brûlures
En fonction du type de plaie, le marché des produits biologiques de traitement des plaies est segmenté en ulcères, plaies chirurgicales et traumatiques et brûlures. Les ulcères veineux sont eux-mêmes segmentés en ulcères, ulcères du pied diabétique, escarres et autres ulcères.
Utilisateur final
- Hôpitaux
- ASC
- Centres de soins aux brûlés
- Cliniques de soins des plaies
- Autres
Sur la base de l'utilisateur final, le marché des produits biologiques de traitement des plaies est segmenté en hôpitaux, centres de soins intensifs, centres de brûlés et cliniques de soins des plaies.
Analyse/perspectives régionales du marché des produits biologiques pour le traitement des plaies
Le marché des produits biologiques pour le traitement des plaies est analysé et des informations sur la taille et les tendances du marché sont fournies par pays, produit, type de plaie et utilisateur final. référencé ci-dessus.
Les pays couverts dans le rapport sur le marché des produits biologiques pour le soin des plaies sont les États-Unis, le Canada et le Mexique en Amérique du Nord, l'Allemagne, la France, le Royaume-Uni, les Pays-Bas, la Suisse, la Belgique, la Russie, l'Italie, l'Espagne, la Turquie, le reste de l'Europe en Europe, la Chine, le Japon, l'Inde, la Corée du Sud, Singapour, la Malaisie, l'Australie, la Thaïlande, l'Indonésie, les Philippines, le reste de l'Asie-Pacifique (APAC) en Asie-Pacifique (APAC), l'Arabie saoudite, les Émirats arabes unis, l'Afrique du Sud, l'Égypte, Israël, le reste du Moyen-Orient et de l'Afrique (MEA) en tant que partie du Moyen-Orient et de l'Afrique (MEA), le Brésil, l'Argentine et le reste de l'Amérique du Sud en tant que partie de l'Amérique du Sud.
L'Amérique du Nord domine le type de produit et de plaie en raison de la prévalence croissante des ulcères du pied diabétique et de la sensibilité accrue aux infections cutanées microbiennes et fongiques. L'Asie-Pacifique devrait croître au cours de la période de prévision 2021-2028 en raison de la présence de pays émergents tels que la Chine, le Japon et l'Inde, ainsi que du développement des infrastructures de santé.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.
Croissance des infrastructures de santé Base installée et pénétration des nouvelles technologies
Le marché des produits biologiques pour le traitement des plaies vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché des produits biologiques pour le traitement des plaies, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché des produits biologiques pour le traitement des plaies. Les données sont disponibles pour la période historique 2010-2020.
Analyse du paysage concurrentiel et des parts de marché des produits biologiques pour le traitement des plaies
Le paysage concurrentiel du marché des produits biologiques pour le traitement des plaies fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des produits biologiques pour le traitement des plaies.
Certains des principaux acteurs opérant sur le marché des produits biologiques pour le traitement des plaies sont
- Smith & Nephew (Royaume-Uni)
- Mölnlycke Health Care AB (Suède)
- Integra LifeSciences Corporation (États-Unis)
- Wright Medical (États-Unis)
- Groupe MiMedx (États-Unis)
- Vericel Corporation (États-Unis)
- Anika Therapeutics (États-Unis)
- Osiris Therapeutics (États-Unis)
- Organogenèse (États-Unis)
- Kerecis (Islande)
- Solsys Medical (États-Unis)
- ACell (États-Unis)
- Lavior Inc. (États-Unis)
- Marine Polymer Technologies, Inc. (États-Unis)
- Smith & Nephew (Royaume-Uni)
- Mölnlycke Health Care AB (Suède)
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
TABLE OF CONTENTS GLOBAL WOUND CARE BIOLOGICS MARKET
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL WOUND CARE BIOLOGICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.1 DBMR MARKET POSITION GRID
2.2 DBMR MARKET CHALLENGE MATRIX
2.3 SECONDARY SOURCES
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING CASES OF DIABETIC FOOT ULCERS
3.1.2 INCREASING INCIDENCES OF BURN CASES
3.1.3 RISING NUMBER OF GERIATRIC POPULATION
3.1.4 INNOVATION IN WOUND CARE BIOLOGICS
3.1.5 NEW PRODUCT LAUNCHES
3.2 RESTRAINS
3.2.1 HIGH COST OF WOUND TREATMENT AND WOUND CARE BIOLOGICS
3.2.2 RISK OF SKIN SUBSTITUE FAILURE
3.3 OPPORTUNITIES
3.3.1 3D SKIN PRINTING
3.3.2 AWARENESS PROGRAMS
3.4 CHALLENGES
3.4.1 LACK OF WOUND MANAGEMENT SERVICES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 SYNTHETIC SKIN GRAFTS
6.3 GROWTH FACTORS
6.3.1 PLATELET DERIVED GROWTH FACTOR (PDGF)
6.3.2 PLATELET RICH PLASMA (PRP)
6.3.3 EPIDERMAL GROWTH FACTORS (EGF)
6.3.4 BASIC FIBROBLAST GROWTH FACTORS (BFGF)
6.3.5 GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF)
6.3.6 TALACTOFERRIN ALFA
6.3.7 THROMBIN PEPTIDE
6.3.8 KERATINOCY GROWTH FACTOR (KGF)
6.4 ALLOGRAFTS
6.5 XENOGRAFTS
7 GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE
7.1 OVERVIEW
7.2 WOUNDS
7.2.1 SURGICAL WOUND
7.2.1.1 SKIN SURGERY
7.2.1.1.1 WOUND CLOSURE
7.2.1.1.2 SKIN BIOPSY
7.2.1.1.3 SKIN FLAP
7.2.1.1.4 SKIN GRAFT
7.2.1.1.5 OTHERS
7.2.1.2 COSMETIC PROCEDURE
7.2.1.2.1 BREST ENHANCEMENT
7.2.1.2.2 FACIAL CONTOURING
7.2.1.2.3 FACIAL REJUVENATION:
7.2.1.2.4 BODY CONTOURING
7.2.1.2.5 SKIN REJUVENATION
7.2.1.2.6 OTHERS
7.2.1.3 GYNECOLOGIC PROCEDURES
7.2.1.3.1 PUBOVAGINALIS SLING
7.2.1.3.2 PELVIC FLOOR RECONSTRUCTION
7.2.1.3.3 RECTOCELE REPAIR SURGERY
7.2.1.3.4 OTHERS
7.2.1.4 GASTROINTESTINAL PROCEDURE
7.2.1.4.1 GENERAL GASTROINTESTINAL SURGERY
7.2.1.4.2 HERNIA
7.2.1.4.3 OTHERS
7.2.2 ACUTE WOUNDS
7.2.3 CHRONIC WOUNDS
7.2.4 TRAUMATIC WOUNDS
7.3 BURNS
7.3.1 ULCERS
7.3.2 DIABETIC ULCERS
7.3.3 PRESSURE ULCER
7.3.4 VENOUS ULCER
7.3.5 OTHERS
8 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 WOUND CARE CENTERS
8.4 AMBULATORY SURGICAL CENTERS
8.5 CLINICS
8.6 COMMUNITY HEALTHCARE CENTER
9 GLOBAL WOUND CARE BIOLOGICS MARKET: GEOGRAPHY
9.1 GLOBAL
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 ITALY
9.3.5 SWITZERLAND
9.3.6 NETHERLANDS
9.3.7 RUSSIA
9.3.8 TURKEY
9.3.9 SPAIN
9.3.10 BELGIUM
9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.5 AUSTRALIA
9.4.6 THAILAND
9.4.7 MALAYSIA
9.4.8 SINGAPORE
9.4.9 INDONESIA
9.4.10 PHILIPPINES
9.4.11 REST OF ASIA-PACIFIC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 REST OF SOUTH AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 SOUTH AFRICA
9.6.2 REST OF MIDDLE EAST & AFRICA
10 GLOBAL WOUND CARE BIOLOGICS MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 COMPANY PROFILE
11.1 MIMEDX.
11.1.1 COMPANY OVERVIEW
11.1.2 REVENUE ANALYSIS:
11.1.3 COMPANY SHARE ANALYSIS:
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPMENTS
11.2 ORGANOGENESIS INC
11.2.1 COMPANY OVERVIEW
11.2.2 GEOGRAPHIC PRESENCE
11.2.3 COMPANY SHARE ANALYSIS:
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPMENTS
11.3 INTEGRA LIFESCIENCES
11.3.1 COMPANY OVERVIEW
11.3.2 REVENUE ANALYSIS
11.3.3 COMPANY SHARE ANALYSIS:
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPMENTS
11.4 CONVATEC INC.
11.4.1 COMPANY OVERVIEW
11.4.2 REVENUE ANALYSIS
11.4.3 COMPANY SHARE ANALYSIS:
11.4.4 PRODUCT PORTFOLIO :
11.4.5 RECENT DEVELOPMENTS
11.5 ACELL INC.
11.5.1 COMPANY OVERVIEW
11.5.2 PRODUCT PORTFOLIO
11.5.3 RECENT DEVELOPMENTS
11.6 ALLOSOURCE
11.6.1 COMPANY OVERVIEW
11.6.2 PRODUCT PORTFOLIO
11.6.3 RECENT DEVELOPMENTS
11.7 ALPHATEC SPINE, INC. ( A SUBSIDARY OF ALPHATEC HOLDINGS, INC)
11.7.1 COMPANY OVERVIEW
11.7.2 PRODUCT PORTFOLIO
11.7.3 RECENT DEVELOPMENTS
11.8 AMNIO TECHNOLOGY, LLC
11.8.1 COMPANY OVERVIEW
11.8.2 PRODUCT PORTFOLIO
11.8.3 RECENT DEVELOPMENTS
11.9 AMNIOX MEDICAL, INC.
11.9.1 COMPANY OVERVIEW
11.9.2 PRODUCT PORTFOLIO
11.9.3 RECENT DEVELOPMENTS
11.10 ANIKA THERAPEUTICS, INC.
11.10.1 COMPANY OVERVIEW
11.10.2 REVENUE ANALYSIS
11.10.3 PRODUCT PORTFOLIO
11.10.4 RECENT DEVELOPMENTS
11.11 BIOHORIZONS IPH, INC ( A SUBSIDARY OF HENRY SCHEIN, INC.)
11.11.1 COMPANY OVERVIEW
11.11.2 GEOGRAPHICPRESENCE
11.11.3 PRODUCT PORTFOLIO
11.11.4 RECENT DEVELOPMENTS
11.12 KERECIS
11.12.1 COMPANY OVERVIEW
11.12.2 GEOGRAPHICAL PRESENCE
11.12.3 PRODUCT PORTFOLIO
11.12.4 RECENT DEVELOPMENTS
11.13 MARINE POLYMER TECHNOLOGIES, INC
11.13.1 COMPANY OVERVIEW
11.13.2 PRODUCT PORTFOLIO
11.13.3 RECENT DEVELOPMENTS
11.14 MÖLNLYCKE HEALTH CARE AB
11.14.1 COMPANY OVERVIEW
11.14.2 REVENUE ANALYSIS
11.14.3 PRODUCT PORTFOLIO
11.14.4 RECENT DEVELOPMENTS
11.15 OSIRIS THERAPEUTICS, INC.
11.15.1 COMPANY OVERVIEW
11.15.2 REVENUE ANALYSIS
11.15.3 PRODUCT PORTFOLIO
11.15.4 RECENT DEVELOPMENTS
11.16 SKYE BIOLOGICS INC.
11.16.1 COMPANY OVERVIEW
11.16.2 PRODUCT PORTFOLIO :
11.16.3 RECENT DEVELOPMENT:
11.17 SMITH AND NEPHEW
11.17.1 COMPANY OVERVIEW
11.17.2 REVENUE ANALYSIS
11.17.3 PRODUCT PORTFOLIO
11.17.4 RECENT DEVELOPMENTS
11.18 SOLSYS MEDICAL.
11.18.1 COMPANY OVERVIEW
11.18.2 PRODUCT PORTFOLIO
11.18.3 RECENT DEVELOPMENTS
11.19 VERICEL CORPORATION.
11.19.1 COMPANY OVERVIEW
11.19.2 1.1.2 REVENUE ANALYSIS
11.19.3 PRODUCT PORTFOLIO
11.19.4 RECENT DEVELOPMENTS
11.20 WRIGHT MEDICAL GROUP N.V
11.20.1 COMPANY OVERVIEW
11.20.2 1.1.2 REVENUE ANALYSIS
11.20.3 PRODUCT PORTFOLIO
11.20.4 RECENT DEVELOPMENTS
12 RELATED REPORTS
Liste des tableaux
LIST OF TABLES GLOBAL WOUND CARE BIOLOGICS MARKET
TABLE 1 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2016– 2025 (USD MILLION)
TABLE 2 GLOBAL SYNTHETIC SKIN GRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 3 GLOBAL GROWTH FACTORS IN WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2016– 2025 (USD MILLION)
TABLE 4 GLOBAL GROWTH FACTORS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 5 GLOBAL ALLOGRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 6 GLOBAL XENOGRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 7 GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2015– 2025 (USD MILLION)
TABLE 8 GLOBAL WOUNDS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 9 GLOBAL WOUNDS IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016– 2025 (USD MILLION)
TABLE 10 GLOBAL SURGICAL WOUND IN WOUND CARE BIOLOGICS MARKET, 2016-2025 (USD MILLION)
TABLE 11 GLOBAL SKIN SURGERY IN WOUND CARE BIOLOGICS MARKET, 2016-2025 (USD MILLION)
TABLE 12 NUMBER OF COSMETIC SURGERY, 2016 & 2017
TABLE 13 GLOBAL COSMETIC SURGERY IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016-2025 (USD MILLION)
TABLE 14 GLOBAL GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016-2025 (USD MILLION)
TABLE 15 GLOBAL GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE 2018-2025 (USD MILLION)
TABLE 16 GLOBAL BURNS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 17 GLOBAL ULCERS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 18 GLOBAL ULCERS IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE 2016-2025 (USD MILLION)
TABLE 19 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER, 2016 – 2025 (USD MILLION)
TABLE 20 GLOBAL HOSPITALS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 21 GLOBAL WOUND CARE CENTER IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 22 STATISTICS FOR AMBULATORY SURGICAL CENTER. U.S.
TABLE 23 GLOBAL AMBULATORY SURGICAL CENTERS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 24 GLOBAL CLINICS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 25 GLOBAL COMMUNITY HEALTHCARE CENTER IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)
TABLE 26 GLOBAL WOUND CARE BIOLOGICS MARKET, BY GEOGRAPHY, USD MILLION (2016-2025)
TABLE 27 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION )
TABLE 28 NORTH AMERICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 29 NORTH AMERICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 30 NORTH AMERICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 31 NORTH AMERICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 32 NORTH AMERICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 33 NORTH AMERICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 34 NORTH AMERICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 35 NORTH AMERICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 36 NORTH AMERICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 37 NORTH AMERICA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 38 NORTH AMERICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 39 U.S. WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 40 U.S. GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 41 U.S. WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 42 U.S. WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 43 U.S. SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 44 U.S. SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 45 U.S. COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 46 U.S. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 47 U.S. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 48 U.S. ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 49 U.S. WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 50 CANADA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 51 CANADA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 52 CANADA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 53 CANADA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 54 CANADA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 55 CANADA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 56 CANADA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 57 CANADA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 58 CANADA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 59 CANADA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 60 CANADA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 61 MEXICO WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 62 MEXICO GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 63 MEXICO WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 64 MEXICO WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 65 MEXICO SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 66 MEXICO SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 67 MEXICO COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 68 MEXICO GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 69 MEXICO GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 70 MEXICO ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 71 MEXICO WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 72 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY, USD MILLION (2016-2025)
TABLE 73 EUROPE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 74 EUROPE GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 75 EUROPE WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 76 EUROPE WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 77 EUROPE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 78 EUROPE SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 79 EUROPE COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 80 EUROPE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 81 EUROPE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 82 EUROPE ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 83 EUROPE WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 84 GERMANY WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 85 GERMANY GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 86 GERMANY WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 87 GERMANY WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 88 GERMANY SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 89 GERMANY SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 90 GERMANY COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 91 GERMANY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 92 GERMANY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 93 GERMANY ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 94 GERMANY WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 95 FRANCE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 96 FRANCE GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 97 FRANCE WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 98 FRANCE WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 99 FRANCE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 100 FRANCE SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 101 FRANCE COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 102 FRANCE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 103 FRANCE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 104 FRANCE ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 105 FRANCE WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 106 U.K. WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 107 U.K. GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 108 U.K. WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 109 U.K. WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 110 U.K. SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 111 U.K. SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 112 U.K. COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 113 U.K. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 114 U.K. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 115 U.K. ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 116 U.K. WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 117 ITALY WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 118 ITALY GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 119 ITALY WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 120 ITALY WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 121 ITALY SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 122 ITALY SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 123 ITALY COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 124 ITALY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 125 ITALY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 126 ITALY ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 127 ITALY WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 128 SWITZERLAND WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 129 SWITZERLAND GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 130 SWITZERLAND WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 131 SWITZERLAND WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 132 SWITZERLAND SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 133 SWITZERLAND SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 134 SWITZERLAND COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 135 SWITZERLAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 136 SWITZERLAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 137 SWITZERLAND ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 138 SWITZERLAND WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 139 NETHERLANDS WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 140 NETHERLANDS GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 141 NETHERLANDS WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 142 NETHERLANDS WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 143 NETHERLANDS SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 144 NETHERLANDS SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 145 NETHERLANDS COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 146 NETHERLANDS GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 147 NETHERLANDS GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 148 NETHERLANDS ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 149 SWITZERLAND WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 150 RUSSIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 151 RUSSIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 152 RUSSIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 153 RUSSIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 154 RUSSIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 155 RUSSIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 156 RUSSIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 157 RUSSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 158 RUSSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 159 RUSSIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 160 RUSSIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 161 TURKEY WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 162 TURKEY GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 163 TURKEY WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 164 TURKEY WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 165 TURKEY SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 166 TURKEY SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 167 TURKEY COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 168 TURKEY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 169 TURKEY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 170 TURKEY ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 171 TURKEY WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 172 SPAIN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 173 SPAIN GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 174 SPAIN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 175 SPAIN WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 176 SPAIN SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 177 SPAIN SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 178 SPAIN COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 179 SPAIN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 180 SPAIN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 181 SPAIN ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 182 SPAIN WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 183 BELGIUM WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 184 BELGIUM GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 185 BELGIUM WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 186 BELGIUM WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 187 BELGIUM SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 188 BELGIUM SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 189 BELGIUM COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 190 BELGIUM GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 191 BELGIUM GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 192 BELGIUM ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 193 BELGIUM WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 194 REST OF EUROPE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 195 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY COUNTRY, 2016-2025, (USD MILLION)
TABLE 196 ASIA-PACIFIC WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 197 ASIA-PACIFIC GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 198 ASIA-PACIFIC WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 199 ASIA-PACIFIC WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 200 EUROPE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 201 ASIA-PACIFIC SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 202 ASIA-PACIFIC COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 203 ASIA-PACIFIC GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 204 ASIA-PACIFIC GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 205 ASIA-PACIFIC ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 206 ASIA-PACIFIC WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 207 CHINA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 208 CHINA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 209 CHINA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 210 CHINA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 211 CHINA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 212 CHINA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 213 CHINA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 214 CHINA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 215 CHINA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 216 CHINA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 217 CHINA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 218 JAPAN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 219 JAPAN GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 220 JAPAN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 221 JAPAN WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 222 JAPAN SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 223 JAPAN SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 224 JAPAN COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 225 JAPAN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 226 JAPAN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 227 JAPAN ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 228 JAPAN WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 229 INDIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 230 INDIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 231 INDIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 232 INDIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 233 INDIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 234 INDIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 235 INDIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 236 INDIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 237 INDIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 238 INDIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 239 INDIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 240 SOUTH KOREA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 241 SOUTH KOREA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 242 SOUTH KOREA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 243 SOUTH KOREA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 244 SOUTH KOREA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 245 SOUTH KOREA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 246 SOUTH KOREA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 247 SOUTH KOREA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 248 SOUTH KOREA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 249 SOUTH KOREA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 250 SOUTH KOREA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 251 AUSTRALIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 252 AUSTRALIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 253 AUSTRALIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 254 AUSTRALIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 255 AUSTRALIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 256 AUSTRALIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 257 AUSTRALIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 258 AUSTRALIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 259 AUSTRALIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 260 AUSTRALIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 261 AUSTRALIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 262 THAILAND WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 263 THAILAND GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 264 THAILAND WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 265 THAILAND WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 266 THAILAND SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 267 THAILAND SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 268 THAILAND COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 269 THAILAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 270 THAILAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 271 THAILAND ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 272 THAILAND WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 273 MALAYSIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 274 MALAYSIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 275 MALAYSIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 276 MALAYSIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 277 MALAYSIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 278 MALAYSIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 279 MALAYSIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 280 MALAYSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 281 MALAYSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 282 MALAYSIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 283 MALAYSIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 284 SINGAPORE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 285 SINGAPORE GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 286 SINGAPORE WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 287 SINGAPORE WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 288 SINGAPORE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 289 SINGAPORE SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 290 SINGAPORE COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 291 SINGAPORE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 292 SINGAPORE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 293 SINGAPORE ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 294 SINGAPORE WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 295 INDONESIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 296 INDONESIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 297 INDONESIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 298 INDONESIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 299 INDONESIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, “2016-2025, (USD MILLION)
TABLE 300 INDONESIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 301 INDONESIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 302 INDONESIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 303 PHILIPPINESGYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 304 INDONESIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 305 INDONESIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 306 PHILIPPINES WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 307 PHILIPPINES GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 308 PHILIPPINES WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 309 PHILIPPINES WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 310 PHILIPPINES SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 311 PHILIPPINES SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 312 PHILIPPINES COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 313 PHILIPPINES GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 314 PHILIPPINESGYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 315 PHILIPPINES ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 316 PHILIPPINESWOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 317 REST OF ASIA-PACIFIC WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 318 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, USD MILLION (2016-2025)
TABLE 319 SOUTH AMERICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 320 SOUTH AMERICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 321 SOUTH AMERICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 322 SOUTH AMERICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 323 SOUTH AMERICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 324 SOUTH AMERICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 325 SOUTH AMERICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 326 SOUTH AMERICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 327 SOUTH AMERICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 328 SOUTH AMERICA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 329 SOUTH AMERICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 330 BRAZIL WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 331 BRAZIL GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 332 BRAZIL WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 333 BRAZIL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 334 BRAZIL SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 335 BRAZIL SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 336 BRAZIL COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 337 BRAZIL GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 338 BRAZIL GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 339 BRAZIL ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 340 BRAZIL WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 341 REST OF SOUTH AMERICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 342 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, USD MILLION (2016-2025)
TABLE 343 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 344 MIDDLE EAST & AFRICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 345 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 346 MIDDLE EAST & AFRICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 347 MIDDLE EAST & AFRICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 348 MIDDLE EAST & AFRICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 349 MIDDLE EAST & AFRICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 350 MIDDLE EAST & AFRICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 351 MIDDLE EAST & AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 352 MIDDLE EAST & AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 353 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 354 SOUTH AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 355 SOUTH AFRICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
TABLE 356 SOUTH AFRICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 357 SOUTH AFRICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 358 SOUTH AFRICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 359 SOUTH AFRICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 360 SOUTH AFRICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 361 SOUTH AFRICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 362 SOUTH AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 363 SOUTH AFRICA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)
TABLE 364 SOUTH AFRICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)
TABLE 365 REST OF MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
Liste des figures
LIST OF FIGURES GLOBAL WOUND CARE BIOLOGICS MARKET
FIGURE 1 GLOBAL WOUND CARE BIOLOGICS MARKET: SEGMENTATION
FIGURE 2 GLOBAL WOUND CARE BIOLOGICS MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL WOUND CARE BIOLOGICS MARKET: RESEARCH SNAPSHOT
FIGURE 4 GLOBAL WOUND CARE BIOLOGICS MARKET: BOTTOM UP APPROACH
FIGURE 5 GLOBAL WOUND CARE BIOLOGICS MARKET: TOP DOWN APPROACH
FIGURE 6 GLOBAL WOUND CARE BIOLOGICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 1 GLOBAL WOUND CARE BIOLOGICS MARKET: DBMR MARKET POSITION GRID
FIGURE 2 GLOBAL WOUND CARE BIOLOGICS MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL WOUND CARE BIOLOGICS MARKET
FIGURE 4 AGING POPULATION IN DIFFERENT COUNTRIES (2014, 2017 & 2020)
FIGURE 5 GLOBAL WOUND CARE BIOLOGICS MARKET: SEGMENTATION
FIGURE 6 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL WOUND CARE BIOLOGICS MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025
FIGURE 7 INCREASING PREVELANCE OF DIABETIC FOOT ULCERS AND INCREASING INCIDENCES OF BURN CASES ARE EXPECTED TO DRIVE THE MARKET FOR GLOBAL WOUND CARE BIOLOGICS IN THE FORECAST PERIOD 2018 TO 2025
FIGURE 8 SYNTHETIC SKIN GRAFTS IN GLOBAL WOUND CARE BIOLOGICS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL WOUND CARE BIOLOGICS MARKET IN 2018 & 2025
FIGURE 9 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GLOBAL WOUND CARE BIOLOGICS MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 62
FIGURE 10 WORLDWIDE PREVALENCE OF VARIOUS WOUND TYPES, 2011
FIGURE 11 CASES OF BURN INJURIES, (2009 – 2012)
FIGURE 12 PREVALENCE OF PRESSURE ULCERS IN FEW COUNTRIES
FIGURE 13 NUMBER OF SURGICAL PROCEDURES AND SURGICAL SITE INFECTIONS
FIGURE 14 GLOBAL WOUND CARE BIOLOGICS MARKET: BY PRODUCT TYPE, 2017
FIGURE 15 GLOBAL WOUND CARE BIOLOGICS MARKET: BY WOUND TYPE, 2017
FIGURE 16 GLOBAL WOUND CARE BIOLOGICS MARKET: BY END USER, SNAPSHOT 2017
FIGURE 17 GLOBAL WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 18 GLOBAL WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 19 GLOBAL WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 20 GLOBAL WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 21 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 22 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 23 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 24 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 25 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 26 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 27 EUROPE WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 28 EUROPE WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 29 EUROPE WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 30 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 31 EUROPE WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 32 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 33 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 34 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 35 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 36 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 37 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 38 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 39 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 40 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 41 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 42 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)
FIGURE 43 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)
FIGURE 44 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)
FIGURE 45 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)
FIGURE 46 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)
FIGURE 47 GLOBAL WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)
FIGURE 48 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)
FIGURE 49 EUROPE WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)
FIGURE 50 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
